Table 2

Summary of patient cohort demographics

Tumor typeNumber of cases (n)Mean age (years)Median age (years)Female patients (%)Specimen site (% samples in each tumor type)
Primary siteMetastaticAmbiguous or unknown
NSCLC19969.769.041.7 (n=83)52.8 (n=105)30.7 (n=61)16.6 (n=33)
Gastrointestinal7065.765.555.7 (n=39)28.6 (n=20)54.3 (n=38)17.1 (n=12)
Gynecological3764.167.0100 (n=37)27.0 (n=11)32.4 (n=12)37.8 (n=14)
Genitourinary1972.372.00 (n=0)52.7 (n=10)26.3 (n=5)21.1 (n=4)
Neuroendocrine tumor1768.770.041.2 (n=7)17.6 (n=3)58.8 (n=12)11.8 (n=2)
Head and neck tumor757.662.071.4 (n=5)0 (n=0)57.1 (n=4)42.9 (n=3)
Melanoma1670.673.031.3 (n=5)50 (n=8)37.5 (n=6)12.5 (n=2)
Soft tissue1559.463.046.7 (n=7)60.0 (n=9)13.3 (n=2)26.7 (n=4)
Central nervous system1051.353.550.0 (n=5)90.0 (n=9)0 (n=0)10.0 (n=1)
Unknown primary malignant neoplasm2863.269.046.4 (n=13)N/AN/AN/A
Total41867.368.548.1 (n=201)39.0 (n=163)32.8 (n=137)28.2 (n=118)
  • NSCLC, non-small cell lung cancer.